{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:20:01Z","timestamp":1789132801182,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jaad.2023.11.039","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T12:33:43Z","timestamp":1701434023000},"page":"731-738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cutaneous squamous cell carcinoma tumor accrual rates in immunosuppressed patients with autoimmune and inflammatory conditions: A retrospective cohort study"],"prefix":"10.1016","volume":"90","author":[{"given":"Emily E.","family":"Granger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Groover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte M.","family":"Proby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Karn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysalyne D.","family":"Schmults","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2023.11.039_bib1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/bjh.15777","article-title":"Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia","volume":"185","author":"Zheng","year":"2019","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.039_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and risk factors for skin cancer in organ transplant recipients in the United States","volume":"153","author":"Garrett","year":"2017","journal-title":"JAMA dermatology"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.039_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.det.2018.07.009","article-title":"Skin cancer and immunosuppression","volume":"37","author":"Collins","year":"2019","journal-title":"Dermatol Clin"},{"issue":"12","key":"10.1016\/j.jaad.2023.11.039_bib4","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/jamadermatol.2017.2984","article-title":"Long-term change in the risk of skin cancer after organ transplantation: a population-based nationwide cohort study","volume":"153","author":"Rizvi","year":"2017","journal-title":"JAMA dermatology"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.039_bib5","first-page":"567","article-title":"Skin cancer risk in autoimmune connective tissue diseases","volume":"149","author":"Kostaki","year":"2014","journal-title":"G Ital Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.jaad.2023.11.039_bib6","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/jamainternmed.2017.4332","article-title":"Malignant neoplasms in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors, tocilizumab, abatacept, or rituximab in clinical practice: a nationwide cohort study from Sweden","volume":"177","author":"Wadstr\u00f6m","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10.1016\/j.jaad.2023.11.039_bib7","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jamadermatol.2019.3056","article-title":"Association of psoriasis with the risk of developing or dying of cancer: a systematic review and meta-analysis","volume":"155","author":"Trafford","year":"2019","journal-title":"JAMA dermatology"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.039_bib8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/j.gastro.2022.05.038","article-title":"Risk of cancer in inflammatory bowel diseases: umbrella review and reanalysis of meta-analyses","volume":"163","author":"Piovani","year":"2022","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.039_bib9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cgh.2020.08.015","article-title":"The risk of extraintestinal cancer in inflammatory bowel disease: a systematic review and meta-analysis of population-based cohort studies","volume":"19","author":"Lo","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.039_bib10","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1053\/j.gastro.2011.07.039","article-title":"Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease","volume":"141","author":"Singh","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.039_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.rbr.2014.03.008","article-title":"Incidence of neoplasms in the most prevalent autoimmune rheumatic diseases: a systematic review","volume":"54","author":"Machado","year":"2014","journal-title":"Rev Bras Reumatol"},{"issue":"7","key":"10.1016\/j.jaad.2023.11.039_bib12","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/1055-9965.EPI-17-0003","article-title":"Spectrum of immune-related conditions associated with risk of keratinocyte cancers among elderly adults in the United States","volume":"26","author":"Yanik","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.039_bib13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.36849\/JDD.2020.4781","article-title":"Risk of non-melanoma skin cancer in connective tissue disease and the impact of immunosuppressive therapy","volume":"19","author":"Gunawardane","year":"2020","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.039_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jaad.2022.11.044","article-title":"Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part I: calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids","volume":"88","author":"Kreher","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.039_bib15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jaad.2022.11.043","article-title":"Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: methotrexate, alkylating agents, biologics, and small molecule inhibitors","volume":"88","author":"Kreher","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.039_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-6143.2012.04292.x","article-title":"A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population","volume":"13","author":"Harwood","year":"2013","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.039_bib17","first-page":"16","article-title":"Yearly burden of skin cancer in non-caucasian and caucasian solid-organ transplant recipients","volume":"8","author":"Ruiz DE Luzuriaga","year":"2015","journal-title":"J Clin Aesthet Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.039_bib18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/ajkd.2003.50130","article-title":"Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia","volume":"41","author":"Carroll","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.039_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/ajd.12072","article-title":"Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution","volume":"55","author":"Ng","year":"2014","journal-title":"Australas J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.039_bib20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jaad.2005.10.049","article-title":"Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series","volume":"54","author":"Harwood","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.039_bib21","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamadermatol.2017.0045","article-title":"Comparison of posttransplant dermatologic diseases by race","volume":"153","author":"Chung","year":"2017","journal-title":"JAMA dermatology"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.039_bib22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jamadermatol.2015.3029","article-title":"Risk of nonmelanoma skin cancer associated with the use of immunosuppressant and biologic agents in patients with a history of autoimmune disease and nonmelanoma skin cancer","volume":"152","author":"Scott","year":"2016","journal-title":"JAMA dermatology"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.039_bib23","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1186\/s12935-021-02325-9","article-title":"Risk of non-melanoma skin cancer with biological therapy in common inflammatory diseases: a systemic review and meta-analysis","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.039_bib24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease","volume":"143","author":"Long","year":"2012","journal-title":"Gastroenterology"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223032498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223032498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:31:08Z","timestamp":1759275068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962223032498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0190962223032498"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2023.11.039","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous squamous cell carcinoma tumor accrual rates in immunosuppressed patients with autoimmune and inflammatory conditions: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2023.11.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}